Muvadenant
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Muvadenant is a hypothetical pharmaceutical compound that has been studied for its potential therapeutic effects in various medical conditions. It is important to note that as of the latest updates, Muvadenant is not an approved drug and remains under investigation in clinical trials.
Pharmacology[edit | edit source]
Muvadenant is believed to act as a selective agonist of the G protein-coupled receptor (GPCR) family, specifically targeting the MuvA receptor subtype. This receptor is implicated in the modulation of neurotransmitter release in the central nervous system, which suggests potential applications in neurological disorders.
Mechanism of Action[edit | edit source]
The mechanism of action of Muvadenant involves binding to the MuvA receptor, leading to a cascade of intracellular events that result in the modulation of synaptic transmission. This action is thought to enhance the release of inhibitory neurotransmitters, thereby exerting a calming effect on neuronal activity.
Clinical Applications[edit | edit source]
Muvadenant is being explored for its use in the treatment of conditions such as anxiety disorders, epilepsy, and chronic pain. Preliminary studies have shown promise in reducing the frequency of seizures and alleviating symptoms of anxiety.
Clinical Trials[edit | edit source]
Several clinical trials are underway to evaluate the safety and efficacy of Muvadenant. These trials are in various phases, ranging from Phase I, which assesses safety and dosage, to Phase III, which evaluates efficacy and monitors adverse reactions in larger populations.
Adverse Effects[edit | edit source]
As with any investigational drug, Muvadenant has been associated with a range of potential side effects. Commonly reported adverse effects include dizziness, nausea, and fatigue. More serious side effects are rare but may include alterations in mood and cognitive function.
Regulatory Status[edit | edit source]
Muvadenant is currently not approved by any major regulatory body such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA). It remains an investigational drug, and its future approval will depend on the outcomes of ongoing clinical trials.
Research and Development[edit | edit source]
The development of Muvadenant is being spearheaded by several pharmaceutical companies in collaboration with academic institutions. Research is focused on optimizing its pharmacokinetic properties and minimizing potential side effects.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
